NEW YORK (Reuters Health) – Systolic blood pressure, left ventricular (LV) mass, and diabetes status independently predict the likelihood that prehypertensive patients with cardiac risk factors will develop…
NEW YORK (Reuters Health) – Transradial percutaneous coronary intervention (PCI) for acute MI is associated with a lower risk of major bleeding and other adverse events than transfemoral…
NEW YORK (Reuters Health) – Treating HER-2 positive, metastatic breast cancer with trastuzumab significantly increased survival in a retrospective study, to the point were such women given the…
NEW YORK (Reuters Health) – In patients receiving glucocorticoids for inflammatory diseases, adverse events are very common, even at low to medium doses, according to a meta-analysis by…
NEW YORK (Reuters Health) – Interruption of cardiopulmonary resuscitation (CPR) compressions is common and prolonged when paramedics attempt to perform endotracheal intubation at the same time, research indicates.…
Robert Shorr, Ph.D, D.I.C, CEO, Cornerstone Pharmaceuticals, discusses how physicians can understand a new oncology drug, starting with knowing its safety limitations. He also explains the structure and…
E. Murat Tuzcu, MD, Professor of Medicine, Cleveland Clinic, discusses the current limitations of catheter-based valve replacements, including problems with the femoral artery route and atherosclerosis and paravalvular…
Imad Najm, MD, Director, Epilepsy Center, Cleveland Clinic, discusses SEEG or Stereo Encephalography for Epilepsy, a new minimally invasive procedure used to localize the areas of seizure onset.…
Gary Falk, MD, MS, Professor of Medicine, Director, Center for Esophageal and Swallowing Disorders, Cleveland Clinic, discusses a new treatment Barrett’s esophagus, radiofrequency ablation, useful in two particular…
NEW YORK (Reuters Health) – An “important” relation exists between platelet reactivity and glycemic control in patients with type 2 diabetes and coronary artery disease who are on…
